3 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 71, n° 1
pages 92-99 (juillet 2014)
Doi : 10.1016/j.jaad.2014.02.030
accepted : 25 February 2014
Original Articles

Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009

Katherine E. Brick, MD a, Chad H. Weaver, MD a, Christine M. Lohse, MS b, Mark R. Pittelkow, MD a, c, Julia S. Lehman, MD a, d, Michael J. Camilleri, MD a, d, Mustafa Al-Hashimi, MD a, Carilyn N. Wieland, MD a, d,
a Department of Dermatology, Mayo Clinic, Rochester, Minnesota 
b Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota 
c Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 
d Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota 

Reprint requests: Carilyn N. Wieland, MD, Department of Dermatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905.

Bullous pemphigoid (BP) is an autoimmune blistering disease that is associated with increased mortality.


We sought to determine the incidence and mortality of patients with BP.


A total of 87 residents of Olmsted County, Minnesota, were identified who had their first lifetime diagnosis of BP from January 1960 through December 2009. Incidence and mortality were compared with age- and sex-matched control patients from the same geographic area.


The adjusted incidence of BP was 2.4 per 100,000 person-years (95% confidence interval, 1.9-2.9). Incidence of BP increased significantly with age (P < .001) and over time (P  = .034). Trend tests indicate increased diagnosis of localized disease (P  = .006) may be a contributing factor. Survival observed in the incident BP cohort was significantly poorer than expected (P < .001). Survival was not different among patients with multisite versus localized disease (P  = .90).


Retrospective study design and study population from a small geographic area are limitations.


Incidence of BP in the United States is comparable with that found in Europe and Asia. The mortality of BP is lower in the United States than Europe, but higher than previous estimates.

The full text of this article is available in PDF format.

Key words : autoimmune blistering disorder, bullous pemphigoid, epidemiology, geriatric, incidence, mortality

Abbreviations used : BP, CI, ELISA

 This study was made possible by the Rochester Epidemiology Project (grant number R01 AG034676 from the National Institute on Aging).
 Conflicts of interest: None declared.

© 2014  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline